Mononucleosis Diagnostics Market to Register a Steady CAGR of 4.5%, During the Forecast Period 2023 – 2031 | Growth Plus Reports

Newark, New Castle, USA, May 01, 2023 (GLOBE NEWSWIRE) — As per the latest study by Growth Plus Reports, the global Mononucleosis Diagnostics Market is expected to register a revenue CAGR of 4.5% by 2031.

The global mononucleosis diagnostics market was valued and expected to rise with a significant revenue share during the forecast period. Mononucleosis is a viral disease generally brought on by the Epstein-Barr virus (EBV). The most common diagnostic test for mononucleosis is the mono spot test, which detects antibodies against EBV in the sample. 

Recent Development in Mononucleosis Diagnostics Market: 

• In October 2022, A functional T cell test for measuring CD4 and CD8 Epstein-Barr virus-specific T cell immune response was introduced by Eurofins Viracor as EBV inSIGHT. The test is now a part of Viracor’s cutting-edge inSIGHT diagnostic suite of virus-specific cell-mediated immunity assays.

Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/mononucleosis-diagnostics-market/8573

                             Mononucleosis Diagnostics Market Scope

Key Takeaways: 

• The rising prevalence of mononucleosis and its diagnosis drives market revenue growth.
• Market consolidation via mergers and acquisitions is broadening product portfolios and market reach.
• The demand for point-of-care testing devices is increasing the rapidity of the diagnosis.

Market Drivers and Restraints: 

The novel immunity booster for better immunity against numerous infectious diseases together with contemporary technology for the introduction of novel diagnostic procedures with enhanced features drives revenue growth for the mononucleosis diagnostic market. Furthermore, the increase in patients and the rising preference of a sizeable portion of the population for affordable and quick examinations drive the market revenue growth.

However, similar symptoms from other viral illnesses potentially hinder the revenue growth of mononucleosis diagnostics by causing misdiagnosis and abuse of the test.

Market Segmentation: 

Segmentation By Test Type

Based on the test type, the global mononucleosis diagnostics market is segmented into monospot test, complete blood count test, and Epstein Barr virus (EBV) antibody test. The monospot test segment accounts for the largest market revenue share, owing to its high accuracy, affordability, and rapidity. 

Segmentation By End User

Based on the end-user, the global mononucleosis diagnostics market is segmented into hospitals, laboratories, and others. The laboratories segment accounts for the largest revenue share in the global market. This large revenue share is attributed to the skilled workers, the availability of required tools, and the high-volume testing conducted each day.  

Regional Growth Dynamics

Based on the region, the global mononucleosis diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounts for the largest revenue share in the global market due to the well-developed healthcare infrastructure, strong research and development studies, and awareness among people for an early diagnosis. 

Competitive Landscape

A list of the market player operating in the global mononucleosis diagnostics market are: 

• Bio-Rad Laboratories Inc.
• Thermo Fischer Scientific Inc.
• Becton, Dickinson, and Company
• Abbott Laboratories Inc.
• Diasorin S.p.A

Request for Customization – https://www.growthplusreports.com/inquiry/customization/mononucleosis-diagnostics-market/8573

Report Coverage 

The report analyzes basic market fundamentals and dynamics, strategies, key investment areas, regional growth analytics, revenue forecast, significant market players, and collaborations. Additionally, the study provides a comprehensive discussion of the global future of the mononucleosis diagnostics market. 

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources 
      1. Secondary Sources 
      2. Primary Sources
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022) 
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL MONONUCLEOSIS DIAGNOSTICS MARKET – ANALYSIS & FORECAST, BY TEST TYPE
   1. Monospot Test
   2. Complete Blood Count Test
   3. Epstein Barr Virus (EBV) Antibody Test
6. GLOBAL MONONUCLEOSIS DIAGNOSTICS MARKET – ANALYSIS & FORECAST, BY END USER
   1. Hospitals
   2. Laboratories
   3. Others

MONONUCLEOSIS DIAGNOSTICS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8573

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse Latest Healthcare Related Reports:

Dermatology Lasers Market by Product (Solid-state Dermatology Lasers, Gas Dermatology Lasers), Application (Hair Removal, Facial Rejuvenation), End User (Hospital, Ambulatory Surgical Centers) – Global Outlook & Forecast 2023-2031

Disabled and Elderly Assistive Technologies Market by Product Type (Mobility Assistive Aids, Bathroom Safety and Assistive Products) End User (Hospitals, Home Care) – Global Outlook & Forecast 2023-2031

Graduated Cylinders Market by Product (System, Reagents), Application (Clinical, Research), End User (Hospitals, Diagnostics Centers) – Global Outlook & Forecast 2023-2031

Migraine Therapeutics Market by Drug Class (CGRP-targeted therapies, Antidepressants, Anticonvulsants, Beta Blockers), Migraine Type (Episodic Migraine, Chronic Migraine), Route of Administration (Oral, Parenteral, Others) – Global Outlook & Forecast 2023-2031

Metered Dose Inhalers Market by Product Type (Breath Actuated pMDIs, Manual Actuated pMDIs), Disease (Asthma, COPD, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook and Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020”.